Accession Number: | 0001209191-14-071389 |
Date: | 2014-11-25 |
Issuer: | AUXILIUM PHARMACEUTICALS INC (AUXL) |
Original Submission Date: |
JOBES ELIZABETH VARKI
C/O AUXILIUM PHARMACEUTICALS, INC.
640 LEE ROAD
CHESTERBROOK, PA 19087
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-11-25 | M | 20,000 | a | $17.68 | 37,819 | direct | ||
COMMON STOCK | 2014-11-25 | M | 3,750 | a | $18.30 | 41,569 | direct | ||
COMMON STOCK | 2014-11-25 | S | 4,052 | d | $34.05 | 37,517 | direct | ||
COMMON STOCK | 2014-11-25 | S | 23,750 | d | $34.03 | 13,767 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NONQUALIFIED STOCK OPTION (RIGHT TO BUY) | 17.68 | 2014-11-25 | deemed execution date | M | 20,000 (d) | 2013-05-07 | 2022-05-07 | common stock 20,000 | $17.68 | 20,000 | direct | |
NONQUALIFIED STOCK OPTION (RIGHT TO BUY) | 18.3 | 2014-11-25 | deemed execution date | M | 3,750 (d) | 2014-02-07 | 2023-02-07 | common stock 3,750 | $18.30 | 11,250 | direct |
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $34.01 to $34.095, inclusive. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $34.015 to $34.095, inclusive. |